Clinical trial

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major…

NCT00430989 · Bayside Health, Other · Completed

Key facts

NCT number NCT00430989
Title The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial
Official title Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).
Lead sponsor Bayside Health, Other
Collaborators National Health and Medical Research Council, Australia
Status Completed
Phase Phase 4
Study type Interventional
Conditions Coronary Artery Disease
Intervention type Other
Interventions Nitrous Oxide, No Nitrous Oxide
Enrollment 7,112
Start date Apr 1, 2007
Primary completion Sep 1, 2013
Completion Sep 1, 2013
First posted Feb 2, 2007
Last update posted Jan 20, 2026
Countries Australia

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies